Burkart, David J <br/><br/>
Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.  [electronic resource] 

 -  Journal of vascular and interventional radiology : JVIR  Jun 2003 
 - 729-33 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1051-0443 
<br/><br/><label>Standard No.: </label>10.1097/01.rvi.0000079981.80153.02  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Arterial Occlusive Diseases--drug therapy<br/>Biomarkers--blood<br/>Disease-Free Survival<br/>Drug Therapy, Combination<br/>Eptifibatide<br/>Female<br/>Femoral Artery--drug effects<br/>Femoral Vein--drug effects<br/>Fibrinogen--drug effects<br/>Fibrinolytic Agents--adverse effects<br/>Follow-Up Studies<br/>Hematocrit<br/>Hemoglobins--drug effects<br/>Hemorrhage--blood<br/>Humans<br/>Iliac Artery--drug effects<br/>Iliac Vein--drug effects<br/>Lower Extremity--blood supply<br/>Male<br/>Middle Aged<br/>Missouri<br/>Peptides--adverse effects<br/>Peripheral Vascular Diseases--drug therapy<br/>Pilot Projects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Popliteal Artery--drug effects<br/>Popliteal Vein--drug effects<br/>Prospective Studies<br/>Tenecteplase<br/>Thrombolytic Therapy<br/>Time Factors<br/>Tissue Plasminogen Activator--adverse effects<br/>Treatment Outcome<br/>Vena Cava, Inferior--drug effects<br/>Venous Thrombosis--drug therapy